EUVIMEDEUVIMED entdecken
Crossref

Postoperative Radiotherapy for Head and Neck Merkel Cell Carcinoma: Sometimes, Less Is More

Yuan Zheng iD, Di Zhang iD, Qihao Sun, Jiaoyang Lu iD

Head & Neck · 2026

DOI: 10.1002/hed.70023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2026. Verfasst von Yuan Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Head and Neck Neoplasms, Skin Neoplasms. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Head and neck Merkel cell carcinoma (HNMCC) is a rare but aggressive malignancy characterized by high recurrence rates and an uncertain survival benefit from postoperative radiotherapy (PORT). This study aimed to develop and validate a prognostic nomogram for risk stratification and to evaluate the survival benefit of PORT across risk groups.

Methods

Patients with surgically resected, non‐metastatic HNMCC were retrospectively identified. Independent prognostic factors for overall survival (OS) were identified via univariate and multivariate Cox regression. A nomogram was constructed and internally validated using time‐dependent receiver operating characteristic curves, calibration plots, and decision curve analysis (DCA). Patients were stratified into high‐ and low‐risk groups based on nomogram scores, and the impact of PORT was assessed within each risk category using Kaplan–Meier analysis and log‐rank tests.

Results

A total of 1776 patients were included. Six variables—age, sex, marital status, race, T stage, and N stage—were independently associated with OS and used to construct the nomogram. The model demonstrated superior discriminative ability and calibration performance compared to traditional staging systems, and DCA confirmed improved clinical utility. Among high‐risk patients, PORT significantly improved 5‐ and 10‐year OS ( p < 0.001), whereas no significant survival benefit was observed in the low‐risk group ( p > 0.05).

Conclusions

This study presents a validated nomogram that accurately predicts survival and supports risk‐adapted use of PORT in HNMCC. Selective application of PORT based on individualized risk may optimize outcomes while minimizing overtreatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Merkel CellHead and Neck NeoplasmsSkin NeoplasmsHumansMaleFemaleRetrospective StudiesAgedMiddle AgedNomogramsRadiotherapy, AdjuvantAged, 80 and overRisk AssessmentPrognosisKaplan-Meier EstimateAdultNeoplasm StagingProportional Hazards ModelsSurvival Analysis

Autor:innen und Institutionen

  • Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Jinan, China.
  • Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.

ORCID-Profile: Yuan Zheng, Di Zhang, Jiaoyang Lu

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

Zheng, Y., Zhang, D., Sun, Q., & Lu, J. (2026). Postoperative Radiotherapy for Head and Neck Merkel Cell Carcinoma: Sometimes, Less Is More. Head & Neck. https://doi.org/10.1002/hed.70023

Vancouver

Zheng Y, Zhang D, Sun Q, Lu J. Postoperative Radiotherapy for Head and Neck Merkel Cell Carcinoma: Sometimes, Less Is More. Head & Neck. 2026. doi:10.1002/hed.70023

BibTeX
@article{Zheng2026,
  author = {Zheng, Yuan and Zhang, Di and Sun, Qihao and Lu, Jiaoyang},
  title = {Postoperative Radiotherapy for Head and Neck Merkel Cell Carcinoma: Sometimes, Less Is More},
  journal = {Head & Neck},
  year = {2026},
  doi = {10.1002/hed.70023}
}
Kostenlos starten →